Pioneering the path to NASH biomarker approval

Nat Med. 2023 Oct;29(10):2416-2417. doi: 10.1038/s41591-023-02527-w.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers
  • Humans
  • Liver
  • Non-alcoholic Fatty Liver Disease*

Substances

  • Biomarkers